Vancouver, Canada

John Priatel

This inventor holds 1 USPTO granted patent. Top assignee: Me Therapeutics Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Priatel. Retrieved from https://idiyas.com/inventor/john-priatel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of John Priatel

Introduction

John Priatel is an accomplished inventor based in Vancouver, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on innovative solutions that address critical health challenges.

Latest Patents

John Priatel holds a patent for "Anti-G-CSF antibodies and uses thereof." This patent discloses methods for making anti-G-CSF antibodies, as well as their applications in treating diseases. The patent also includes methods for screening the activity of these antibodies, pharmaceutical compositions, and kits containing anti-G-CSF antibodies.

Career Highlights

John Priatel is associated with Me Therapeutics Inc., where he continues to advance his research and development efforts. His expertise in antibody technology has positioned him as a key player in the biotechnology sector.

Collaborations

Some of his notable coworkers include Salim Dhanji and Kenneth Harder, who collaborate with him on various projects within the company.

Conclusion

John Priatel's innovative work in the field of anti-G-CSF antibodies exemplifies the impact of biotechnology on modern medicine. His contributions continue to pave the way for new therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…